Similarly to CP13, the pS262 tau antibody detected 65–70 kDa species in AD brain but not in controls and these tau species were also found to be significantly increased in AD, as previously shown [23] (Fig. 4d; p < 0.01). Here, MAPT is linked to Alzheimer disease.